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Background: The optimal glycosylated hemoglobin (HbA1c) level in diabetic patients remained to be controversial era, but may be especially 
important in predicting the prognosis of diabetic patients with acute myocardial infarction (AMI). The aim of this study was to identify the predictive 
value of preprocedural HbA1c levels for cardiac events during mid-term follow-up period in diabetic patients complicated by AMI and underwent 
percutaneous coronary intervention (PCI).
Methods: A total of 2,324 AMI patients (65.0±11.4 years, 62.9% males) enrolled in a nationwide prospective Korea Working Group on Myocardial 
Infarction (KorMI) between Jan. 2008 and Aug. 2010 were included in the present study. The study population were diabetic patients complicated by 
AMI and underwent PCI and followed up during 12 months period. They were categorized into two groups by the level of preprocedural HbA1c (Group 
I: >6.5%, n=1,866; Group II: ≤6.5%, n=458). Major adverse cardiac events (MACE) included cardiac death, recurrent myocardial infarction, and 
re-PCI.
Results: Baseline clinical characteristics were similar between two groups, but group I were younger (63.3±11.4 vs. 67.6±11.0, p<0.001), smoker 
(35.7% vs. 30.1%, p=0.031) and had lesser history of hypertension (58.9% vs. 77.5%, p<0.001). Laboratory findings showed lower glomerular 
filtration rate (GFR) in group II (72.3±35.8mL/min vs. 64.5±34.3mL/min, p<0.001), and coronary angiographic findings showed no meaningful 
difference except more frequent involvement of left anterior descending artery in group I (48.4% vs. 41.9%, p = 0.026). Rates of MACEs during 12 
months were similar between two groups (17.5% vs. 21.0%, p = 0.175). By multivariate analysis, old age, low GFR, high Killip class on admission 
were independently associated with MACEs, but HbA1c was not associated with poor patient outcome during mid-term follow-up period.
Conclusion: This study suggested that HbA1c is not a predictor of cardiac events in diabetic patients with AMI. These results suggest the absence 
of benefit of a strict hyperglycemia control in macrovascular complications, especially coronary artery disease such as myocardial infarction.
